The Enterprise Value as of November 2024 (TTM) for Nuvalent, Inc. (NUVL) is 6.38B

According to Nuvalent, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.38B. This represents a change of 26.02% compared to the average of 5.06B of the last 4 quarters.

Nuvalent, Inc. (NUVL) Historical Enterprise Value (quarterly & annually)

How has NUVL Enterprise Value performed in the past?

The mean historical Enterprise Value of Nuvalent, Inc. over the last ten years is 1.57B. The current 6.38B Enterprise Value has changed 40.57% with respect to the historical average. Over the past ten years (40 quarters), NUVL's Enterprise Value was at its highest in in the September 2024 quarter at 6.35B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Nuvalent, Inc. (NUVL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nuvalent, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nuvalent, Inc. (NUVL) Average Enterprise Value

How has NUVL Enterprise Value performed in the past?

The current Enterprise Value of Nuvalent, Inc. (NUVL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nuvalent, Inc. (NUVL) Enterprise Value vs. Peers

How is NUVL’s Enterprise Value compared to its peers?

Nuvalent, Inc.’s Enterprise Value is less than DICE Therapeutics, Inc. (0), greater than Arcellx, Inc. (1.82B), greater than Vaxcyte, Inc. (4.79B), less than Viridian Therapeutics, Inc. (10.01B), greater than Ventyx Biosciences, Inc. (1.42B), greater than Cullinan Oncology, Inc. (80.09M), greater than Kiniksa Pharmaceuticals, Ltd. (630.54M), greater than Replimune Group, Inc. (1.45B), greater than Ascendis Pharma A/S (984.10M), less than United Therapeutics Corporation (7.61B), less than Cerevel Therapeutics Holdings, Inc. (15.49B), less than Travere Therapeutics, Inc. (8.24B), greater than Structure Therapeutics Inc. (1.95B), greater than null (1.75B),

Build a custom stock screener for Nuvalent, Inc. (NUVL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvalent, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuvalent, Inc. (NUVL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuvalent, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.